Obstacles to CBD Analysis The strict regulations girding cannabis research are finally becoming undone. Clinical proof has demonstrated that CBD is an efficient treatment plan for specific ailments, especially drug-resistant epileptic syndromes1. But, clinical researchhas been severely limited within the forms of studies which they become permitted to conduct. As opposed to acknowledging CBD as a medication that is potential the federal government’s place has gone to demonize it. Cannabis is controlled as a Schedule we medication. It’s still feasible to conduct research on Schedule I substances, nevertheless the hurdles included are incredibly complex that lots of organizationscannot dedicate the resources required to make the research feasible. Scientists who want to learn CBD, or conduct medical studies with it, are expected to register using the Drug Enforcement Agency (DEA), a time-consuming and process that is tedious. There’s currently only 1 legal supply of research-grade cannabis, which is the nationwide Institute on Drug Punishment (NIDA).